METANIUM NAPPY RASH OINTMENT

Active substance: TITANIUM SALICYLATE

View full screen / Print PDF » Download PDF ⇩

Transcript
Crimp area

77 mm

For the treatment of nappy rash - it is important that you
follow these instructions carefully. After removing the
soiled nappy, clean and wash the affected area, drying with a
soft towel. After washing your hands, dab a small amount
(pea size) of Metanium Ointment over the sore area with your
fingertip. It is important to spread this thinly so that the
skin texture can be clearly seen through it. Repeat at each
nappy change to treat nappy rash. Keep the tube nozzle clean
of residue product to ensure the cap can be closed tightly.
Do not use Metanium Ointment if your baby is hypersensitive
to any of its ingredients. Very rarely Metanium Ointment can
cause skin irritation. If any unusual effects occur, discontinue
use and consult your pharmacist or doctor.
If symptoms persist consult your doctor.
FOR EXTERNAL USE ONLY
Keep out of the sight and reach of children.
Caution: Product may stain fabrics.

! If baby accidentally swallows some see a doctor straight
away. Take the pack with you to show which medicine has
been swallowed.
Ointment for topical use.
Active Ingredients:
Titanium dioxide 20% w/w, Titanium peroxide 5% w/w,
Titanium salicylate 3% w/w.
Also contains: Dimethicone 350, light liquid paraffin,
tincture of benzoin and white soft paraffin.
Do not store above 25ºC.
MA Holder and Manufacturer:
Thornton & Ross Ltd., Linthwaite, Huddersfield,
HD7 5QH, UK.
Metanium® is a registered trademark
PL 00240/0366
Do not use this product after the expiry date.

24247904

®

Nappy Rash Ointment
(titanium dioxide, titanium peroxide, titanium salicylate)
soothes & treats

127 mm

MHRA Header Box
Colours Used

Product
Title

Metanium Nappy Rash Ointment

Component

Tube

PANTONE 106 C

Pack Size

30g

Keyline (Does not print)

IG Code

24247904

Dimensions

127mm x 25mm (diameter)

Proof No.

1

PANTONE 7671 C

Date

28.03.2014

Data Matrix: 24247904 VERIFIED

PCP Header Box
Operator

Approved by
Date

chris.jenney

Artwork No 481729
Suf fix

CRN

11073

Reason for
Change

Add instructions on actions if
ingested. Ref. CAPA 1850.

B

Issued by
Date

MHRA/IMB
submission Yes
required

Fonts Used

Helvetica Neue

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)